{"title": "Medicamentos para el ojo seco mejorados para 2022 y m\u00e1s adelante", "author": "Daniel Porter", "url": "https://www.aao.org/salud-ocular/consejos/medicamentos-para-el-ojo-seco-mejorados-para-2022-", "hostname": "aao.org", "description": "Los nuevos medicamentos prescritos para las enfermedades de la superficie ocular, incluyendo el ojo seco, se muestran prometedores en los ensayos cl\u00ednicos. Aqu\u00ed hay un resumen de los medicamentos que", "sitename": "American Academy of Ophthalmology", "date": "2022-01-30", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Se han introducido pocas opciones de tratamiento nuevas para la enfermedad del\n[ojo seco](/salud-ocular/enfermedades/ojo-seco), a pesar de que es una de las afecciones oculares m\u00e1s comunes e inc\u00f3modas.\nEsa es una de las razones por las que casi la mitad de los 16 millones de norteamericanos diagnosticados con ojo seco se sienten frustrados, seg\u00fan una encuesta reciente.\nEl ojo seco es una enfermedad de la superficie ocular (ESO)\nEl ojo seco es una de las enfermedades de la superficie ocular, o ESOs, m\u00e1s comunes. Hay alrededor de media docena de EOSs, y cada enfermedad tiene una causa subyacente \u00fanica \u2014 por eso el mismo tratamiento no funciona en todos los casos.\nDiagnosticar y tratar la ESO puede ser complicado y puede requerir mucho tiempo. Los pacientes generalmente necesitan una combinaci\u00f3n de terapias, adem\u00e1s de\n[cambios en el estilo de vida](/salud-ocular/consejos/como-puedo-saber-la-causa-de-mi-ojo-seco), para brindar un alivio efectivo y duradero.\nPero, con frecuencia, los tratamientos no funcionan de inmediato o causan picaz\u00f3n, ardor o irritaci\u00f3n en los ojos. Es por eso que muchos pacientes dejan de tomar su medicaci\u00f3n para el ojo seco.\n\u201cEstos efectos secundarios pueden aumentar en ojos que ya est\u00e1n inflamados por una enfermedad de la superficie ocular como el ojo seco\u201d, explica el oftalm\u00f3logo y portavoz de la Academia, Dr. Christopher Starr, especialista en ojo seco del Weill Cornell Medical Center.\nLos nuevos tratamientos para el ojo seco pueden ser m\u00e1s efectivos que los ya existentes\nPara los pacientes que se sienten frustrados con las opciones de tratamiento actuales, la esperanza est\u00e1 en el horizonte. Los medicamentos innovadores para el tratamiento de las ESOs de todo tipo \u2014 incluido el ojo seco \u2014 se muestran prometedores en los ensayos cl\u00ednicos. Los oftalm\u00f3logos est\u00e1n entusiasmados y optimistas acerca de ampliar su reserva de herramientas de tratamiento.\nAqu\u00ed hay un resumen de lo que est\u00e1 disponible actualmente y lo que los pacientes pueden esperar en los pr\u00f3ximos a\u00f1os.\nTratamientos existentes para el ojo seco\nLos tratamientos actuales para las enfermedades de la superficie ocular incluyen cambios en el estilo de vida, un aerosol nasal,\n[tapones para el conducto lagrimal](/salud-ocular/tratamientos/tapones-lagrimales), medicamentos antinflamatorios, [dispositivos de limpieza profunda y lentes de contacto especializados](/salud-ocular/consejos/12-tratamientos-para-el-ojo-seco-lo-que-los-pacien).\nEn la actualidad hay cinco medicamentos prescritos disponibles aprobados por la FDA:\n-\n[Tyrvaya](https://www.tyrvaya.com/) (Oyster Point) \u2014 Este aerosol nasal tan esperado para el ojo seco fue aprobado por la Administraci\u00f3n de Alimentos y Drogas de los Estados Unidos en octubre de 2021. El spray, el primer tratamiento de su tipo, estimula la producci\u00f3n de [l\u00e1grimas](/salud-ocular/anatomia/pelicula-lagrimal), grasa y mucina. Este aerosol nasal puede ser m\u00e1s f\u00e1cil de aplicar que las gotas para los ojos y elimina las sensaciones indeseables de ardor y molestia ocular.\n-\n[Restasis](https://www.restasis.com/) (Allergan) y [Cequa](https://www.restasis.com/) (Sun Ophthalmics) \u2014 Estos medicamentos se desarrollaron espec\u00edficamente para el ojo seco cr\u00f3nico, donde la inflamaci\u00f3n reduce la producci\u00f3n de l\u00e1grimas. El ingrediente activo es la ciclosporina. Los pacientes se aplican una gota en cada ojo dos veces al d\u00eda. El tratamiento puede tardar de 3 a 6 meses en comenzar a funcionar y puede causar ardor o malestar temporal.\n-\n[Xiidra](https://www.xiidra.com/) (Novartis) \u2014 Este es un tipo diferente de gota antiinflamatoria que utiliza lifitegrast como ingrediente activo. Este medicamento puede tardar hasta 3 meses en aliviar los s\u00edntomas y hasta una cuarta parte de los pacientes experimentan irritaci\u00f3n y una sensaci\u00f3n de sabor inusual.\n-\n[Eysuvis](https://www.eysuvis.com/) (Kala Pharmaceuticals) \u2014 Este es el primer corticosteroide ocular (loteprednol) aprobado por la FDA para el tratamiento de los brotes de ojo seco. Solo se puede usar durante 2 semanas a la vez, debido a los efectos secundarios de los esteroides. Los pacientes se aplican cuatro gotas al d\u00eda en cada ojo. Eysuvis act\u00faa m\u00e1s r\u00e1pidamente que los medicamentos basados en inmuno-moduladores, y ambos pueden utilizarse en conjunto para aliviar los s\u00edntomas.\nLos nuevos tratamientos para el ojo seco se enfocan en los problemas subyacentes\nInflamaciones subyacentes\nLa ciclosporina no es una forma nueva para tratar el ojo seco. Pero\n[MC2 Therapeutics](https://www.mc2therapeutics.com/pipeline-products/) y [Novaliq](https://www.novaliq.com/products/cyclasol/) est\u00e1n probando nuevos tratamientos antiinflamatorios a base de ciclosporina que pueden ser m\u00e1s efectivos para tratar esta afecci\u00f3n.\nDisfunci\u00f3n de la gl\u00e1ndula de Meibomio\nDos nuevos tratamientos pueden ayudar a las personas que carecen de suficientes aceites saludables, para evitar que sus l\u00e1grimas se evaporen demasiado r\u00e1pido. Estos aceites son producidos por las\n[gl\u00e1ndulas de Meibomio](/salud-ocular/anatomia/glandulas-de-meibomio) a lo largo del borde de los [p\u00e1rpados](/salud-ocular/anatomia/parpado). Hasta ahora, las terapias se han limitado a exfoliaciones de p\u00e1rpados, masajes y compresas tibias.\n-\n[NOV03](https://www.ophthalmologytimes.com/view/bausch-lomb-announces-topline-results-for-phase-iii-trial-of-nov03-to-treat-ded-associated-with-mgd) (Bausch & Lomb) es una gota para los ojos sin conservantes que se administra cuatro veces al d\u00eda para estabilizar las l\u00e1grimas y evitar la evaporaci\u00f3n. Los pacientes en un ensayo cl\u00ednico de fase 3 experimentaron una r\u00e1pida disminuci\u00f3n de la resequedad despu\u00e9s de utilizar las gotas. Este medicamento podr\u00eda convertirse en el primer medicamento prescrito aprobado por la FDA para esta afecci\u00f3n.\n-\n[AZR-MD-001](https://www.businesswire.com/news/home/20210303005272/en/Azura-Ophthalmics-Announces-Positive-Topline-Results-From-Phase-2-Program-of-the-Company%E2%80%99s-Investigational-Treatment-for-Meibomian-Gland-Dysfunction) de Azura Ophthalmicsm, es una pomada que previene la acumulaci\u00f3n de prote\u00ednas en los conductos de las gl\u00e1ndulas de Meibomio. Esta acumulaci\u00f3n bloquea la secreci\u00f3n de aceite y conduce a la resequedad. Los pacientes que probaron el medicamento en un ensayo de fase 2 produjeron cantidades m\u00e1s saludables de aceite y redujeron los s\u00edntomas del ojo seco.\nBlefaritis anterior\nSe est\u00e1 desarrollando un medicamento innovador para tratar la\n[blefaritis](/salud-ocular/enfermedades/que-es-la-blefaritis) causada por los \u00e1caros Demodex. Estos peque\u00f1os insectos viven de forma inofensiva en pr\u00e1cticamente la piel de todas las personas, pero una superpoblaci\u00f3n de ellos en los p\u00e1rpados puede provocar inflamaci\u00f3n, formaci\u00f3n de costras y picaz\u00f3n.\nSe cree que Demodex causa aproximadamente la mitad de todos los casos de blefaritis anterior. Hasta ahora, las \u00fanicas opciones de tratamiento han sido exfoliantes de p\u00e1rpados en el hogar o tratamientos en el consultorio con dispositivos de microblefaroexfoliaci\u00f3n como BlephEx.\n[TP-03](https://www.nature.com/articles/d43747-021-00059-1) de Tarsus Pharmaceuticals es una gota para los ojos administrada dos veces al d\u00eda que ayuda a exterminar los \u00e1caros y mejorar los s\u00edntomas. En un ensayo cl\u00ednico de fase 2b, el tratamiento b\u00e1sicamente elimin\u00f3 la infestaci\u00f3n en m\u00e1s del 80% de los pacientes despu\u00e9s de 43 d\u00edas. Esta terapia podr\u00eda estar disponible a partir del a\u00f1o 2022.\nConjuntivitis al\u00e9rgica\nEl ojo seco suele ir acompa\u00f1ado de una\n[conjuntivitis al\u00e9rgica](/salud-ocular/enfermedades/alergias), lo que produce ojos rojos, hinchados, con picaz\u00f3n o llorosos. Los m\u00e9dicos suelen prescribir gotas para los ojos que contienen antihistam\u00ednicos o esteroides. Estos tratamientos no son ideales: los esteroides pueden aumentar la presi\u00f3n ocular y aumentar el riesgo de infecci\u00f3n y cataratas, si se usan durante largos per\u00edodos de tiempo. La conjuntivitis al\u00e9rgica y el ojo seco suelen ser afecciones cr\u00f3nicas que requieren un tratamiento a largo plazo.\nDos nuevas terapias pueden ofrecer mejores opciones para las personas con conjuntivitis al\u00e9rgica.\n-\n[Reproxalap](https://www.healio.com/news/ophthalmology/20210427/reproxalap-meets-endpoints-in-phase-3-allergic-conjunctivitis-trial) de Aldeyra Therapeutics, es un nuevo tratamiento antiinflamatorio sin los efectos secundarios comunes de los esteroides. En un ensayo cl\u00ednico de fase 3, los pacientes que recibieron el medicamento 4 veces al d\u00eda durante 12 semanas, experimentaron mejoras en la resequedad, enrojecimiento y picaz\u00f3n pocas horas despu\u00e9s de comenzar el tratamiento. Sus efectos secundarios eran m\u00ednimos. Esta terapia puede estar disponible en los pr\u00f3ximos a\u00f1os.\n- Otro antiinflamatorio no esteroide llamado\n[IC 265](http://iactapharma.com/products/ic-265/) de Iacta Pharma, tambi\u00e9n muestra potencial para el tratamiento de alergias oculares cr\u00f3nicas. En un ensayo de fase 2 de pacientes con conjuntivitis al\u00e9rgica, el medicamento redujo el enrojecimiento y la inflamaci\u00f3n en cuesti\u00f3n de horas y fue bien tolerado. A continuaci\u00f3n: el tratamiento se probar\u00e1 en pacientes con enfermedad del ojo seco.\nUve\u00edtis anterior\nUn tratamiento antiinflamatorio puede resultar eficaz tanto para el ojo seco como para la\n[uve\u00edtis](/salud-ocular/enfermedades/que-es-la-uveitis) anterior. La uve\u00edtis se refiere a un grupo de enfermedades inflamatorias que produce hinchaz\u00f3n y destruye el tejido ocular. Estas afecciones normalmente se tratan con gotas, inyecciones o p\u00edldoras de corticosteroides \u2014 lo que no es ideal para un uso prolongado.\n[OCS-02](https://oculis.com/ocs-02-uveitis/) de Oculis, es un medicamento t\u00f3pico que puede reducir eficazmente la inflamaci\u00f3n de la uve\u00edtis y aliviar el malestar causado por el ojo seco, seg\u00fan un ensayo cl\u00ednico de fase 2. El tratamiento fue bien tolerado sin causar efectos secundarios de tipo esteroide. Seguir\u00e1 prob\u00e1ndose en ensayos futuros.\n\u201cTener una gama m\u00e1s amplia de opciones dirigidas a m\u00e1s subtipos de ojo seco y enfermedades de la superficie ocular, ayudar\u00e1 a los oftalm\u00f3logos a personalizar mejor los tratamientos. Esto deber\u00eda conducir a una mayor eficacia y un alivio de los s\u00edntomas m\u00e1s r\u00e1pido para los pacientes\u201d, sostiene el Dr. Starr.", "language": null, "image": "https://d31g6oeq0bzej7.cloudfront.net/Assets/image/jpeg/cbe5a0b1-014f-463a-beae-17a47a14ff27.jpg", "pagetype": "article", "links": ["#contentZone", "#menu", "/dashboard", "/my-education", "https://secure.aao.org/aao/find-ophthalmologist", "/", "/ophthalmologists", "/meetings", "/annual-meeting", "/annual-meeting/meeting-information", "/annual-meeting/past-and-future-meetings", "/annual-meeting/mobile-meeting-guide", "/annual-meeting/contact", "/annual-meeting/news", "/annual-meeting/health-safety", "/annual-meeting/policies-and-disclaimers", "/program", "/annual-meeting/highlights", "/annual-meeting/subspecialty-day", "/annual-meeting/virtual-meeting", "/annual-meeting/program-committees", "/annual-meeting/cme", "/annual-meeting/meeting-archives", "/annual-meeting/exhibition", "/annual-meeting/registration", "/annual-meeting/hotel-reservation", "/annual-meeting/hotel-reservation", "/annual-meeting/san-francisco", "/annual-meeting/international-attendees", "/annual-meeting/hotel-meeting-space", "/annual-meeting/presenter", "/annual-meeting/presenter/overview", "/annual-meeting/presenter/abstract-selection-process", "/annual-meeting/presenter/submission-policies", "/annual-meeting/presenter/subject-classification-topics", "/annual-meeting/presenter/instruction-courses-and-skills-transfer-labs", "/annual-meeting/presenter/paper-posters", "/annual-meeting/presenter/videos", "/annual-meeting/presenter/grand-round", "/annual-meeting/presenter/guidelines", "/annual-meeting/presenter/faculty-development", "/annual-meeting/exhibitor", "/annual-meeting/exhibitor/general-information", "/annual-meeting/exhibitor/portal", "/annual-meeting/exhibitor/new-exhibiting-companies", "/annual-meeting/exhibitor/resources", "/annual-meeting/exhibitor/international-exhibitors", "/annual-meeting/exhibitor/promotional-opportunities", "/annual-meeting/exhibitor/hotel", "/mid-year-forum", "/mid-year-forum/registration-travel", "/mid-year-forum/congressional-advocacy-day", "/mid-year-forum/advocacy-ambassador-program", "/mid-year-forum/program", "/mid-year-forum/schedule", "/mid-year-forum/sponsored-attendee-reimbursement", "/mid-year-forum/news", "/practice-management/coding/codequest", "/practice-management/coding/codequest-instructors", "/practice-management/coding/codequest/cme", "/eyecelerator", "/clinical-education", "/education-browse", "/education-browse", "/education-course", "/education-case", "/education-learning-plan", "/interactive", "/focalpoints", "/wills-eye-manual", "/disease-reviews", "/clinical-webinars", "/education-diagnose-this", "/self-assessments", "/glaucoma-education-center", "/pediatric-ophthalmology-education-center", "/global-ophthalmology-guide", "/laser-surgery-education-center", "/redmond-ethics-center", "/myopia-resources", "/thyroid-eye-disease", "/journals", "/guidelines-browse", "/guidelines-browse", "/education/covid-19", "https://www.aao.org/education/pseudomonas-outbreak", "/preferred-practice-patterns", "/clinical-statements", "/compendium-guidelines", "/complementary-therapy-assessments", "/medical-information-technology-guidelines", "/ophthalmic-technology-assessments", "/patient-safety-statements", "/choosing-wisely", "/low-vision-and-vision-rehab", "/eye-care-for-older-adults", "/eye-disease-statistics", "/about-hoskins-center", "/education/browse-multimedia?filter=Video&sub=ONE.ContentTypes.ONEVideo", "/education/browse-multimedia?filter=Video&sub=ONE.ContentTypes.ONEVideo", "/1-minute-videos", "/presentations-and-lectures", "/master-class-videos", "/clinical-and-surgical-videos", "/multimedia-basic-skills", "/interviews", "/multimedia-images", "/submit-an-image", "/submit-a-video", "/podcasts", "https://www.aao.org/education/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio", "/education/audio/experts-insight", "/education/audio/ophthalmology-journal", "/browse-news", "/browse-news", "/editorschoice", "/headlines", "/currentinsight", "/cme-central", "/cme-central", "/certification", "/claim-cme-credit-and-view-transcript", "/cme-planning-resources", "/complete-your-financial-disclosure", "/leo-continuing-education-recognition-award", "/safe-er-la-opioid-prescribing", "/check-your-industry-payment-records", "/residents", "/residents", "/browse-all-resident-content", "/resident-blog-posts", "/resident-courses", "/resident-flashcards", "/interactive-cases-and-simulations", "/resident-videos", "/resident-webinars", "/cataract-master", "/diversity-and-inclusion-education", "/news-and-advice-from-yo-info", "/okap-and-board-exam-resources", "/okap-exam", "/board-prep-resources", "/okap-study-presentations", "/flashcards", "/pediatric-ophthalmology-education-center-residents", "/pgy-1-and-pgy-2-resources", "/resident-knowledge-exchange", "/simulation-in-resident-education", "https://ophthjobs.aao.org", "/membership-transfer", "/membership/join", "/membership/renew", "/membership/current-member", "/membership/volunteer", "/membership/physician-wellness", "/member-directory", "/membership/obituaries", "/membership/aaoe", "/advocacy", "/advocacy/eye-on-advocacy", "/advocacy/action", "/advocacy/action/give", "/advocacy/action/how-to-get-involved", "/advocacy/action/congressional-advocacy", "/advocacy/action/support-oppose-bills", "/advocacy/action/look-up-bill", "/action/contact-legislator", "/advocacy/i-am-an-advocate", "/advocacy/action/local", "/advocacy/action/vv", "/advocacy/action/best-practices", "/get-involved/social-media-toolkit", "/get-involved/letter-to-editor", "/get-involved/town-hall-guide", "/get-involved/guide-to-engaging-with-new-lawmakers", "/get-involved/resources", "/get-involved/attending-a-political-fundraiser", "/advocacy/ophthpac", "/advocacy/ophthpac/about", "/advocacy/ophthpac/contribute", "/advocacy/ophthpac/blog", "/advocacy/surgical-scope-fund", "/advocacy/surgical-scope-fund/contribute", "/advocacy/surgical-scope-fund/blog", "/eyenet-magazine", "/eyenet", "/eyenet/archives", "/eyenet/subscribe", "/eyenet/advertise", "/eyenet/write-for-us", "/eyenet/corporate-events", "/eyenet/contact", "/eyenet/mips-manual-2022", "/focalpoints", "https://secure.aao.org/aao/aao-redirect?redirectid=100&article=http%3a%2f%2fwww.aaojournal.org%2f", "https://secure.aao.org/aao/aao-redirect?redirectid=100&article=https%3a%2f%2Fwww.ophthalmologyglaucoma.org", "https://secure.aao.org/aao/aao-redirect?redirectid=100&article=https%3a%2f%2Fwww.ophthalmologyretina.org", "https://www.ophthalmologyscience.org/", "https://www.aao.org/young-ophthalmologists/yo-info", "https://www.aao.org/senior-ophthalmologists/scope", "/cataract-anterior-segment", "/comprehensive-ophthalmology", "/cornea-external-disease", "/glaucoma", "/neuro-ophthalmology-orbit", "/ocular-pathology-oncology", "/oculoplastics-orbit", "/pediatric-ophthalmology-strabismus", "/refractive-management-intervention", "/retina-vitreous", "/uveitis", "/iris-registry", "/iris-registry/about", "/iris-registry/ways-to-use", "/iris-registry/userguide", "/iris-registry/medicare-reporting", "/iris-registry/maintenance-of-certification", "/iris-registry/web-portal-reporting", "/iris-registry/sign-up", "/iris-registry/application-process", "/iris-registry/why-participate", "/iris-registry/getting-started-system-integration", "/sign-up/what-practices-are-saying-about-the-registry", "/iris-registry/requirements", "/iris-registry/ehr-systems", "/iris-registry/data-technical-needs", "/iris-registry/research", "/iris-registry/portal", "/iris-registry/news", "/medicare", "/medicare-information", "/diversity-equity-and-inclusion", "/practice-management", "/practice-management/managing-your-practice", "/practice-management/managing-your-practice/managing-practice-index", "/practice-management/resources/coronavirus-resources", "/practice-management/resources/reopening-recovery", "/practice-management/practice-forms-library", "/practice-management/articles-list", "/practice-management/listserv-overview", "/practice-management/resources/videos", "https://ophthjobs.aao.org/", "/practice-management/analytics", "https://store.aao.org/consultation-services", "/practice-management/consultant-directory", "/practice-management/coding", "/practice-management/coding/coding-index", "/practice-management/coding/codequest", "/practice-management/coding-news", "/practice-management/coding/updates-resources", "/practice-management/coding/injectable-drugs", "/practice-management/coding/em-codes", "/practice-management/coding/icd-10-cm", "/practice-management/coding/ocs-specialist-exam", "/practice-management/coding/retina", "/practice-management/coding/savvy-coder", "/practice-management/annual-meeting", "/practice-management/annual-meeting-courses/master-classes", "/practice-management/annual-meeting-courses/coding-sessions", "/submit-an-instruction-course", "/codequest-courses", "/mid-year-forum/overview", "/practice-management/resources/videos", "/upcoming-webinars", "/iris-registry", "/medicare/mips", "/medicare", "/medicare/mips", "/medicare/quality-overview", "/medicare/promoting-interoperability", "/medicare/improvement-activities-overview", "/medicare/cost", "/medicare/avoid-a-penalty", "/medicare/resources", "/practice-management/regulatory/medicare-participation-options", "/practice-management/regulatory/medicare-advantage-plans", "/practice-management/regulatory/medicare-card-2019", "/practice-management/regulatory/pecos", "/practice-management/regulatory/regulatory-compliance", "/practice-management/regulatory/hipaa-resources", "/practice-management/regulatory/regulatory-compliance#oig", "/practice-management/regulatory/audits", "/practice-management/regulatory/regulatory-compliance#osha", "/membership/aaoe", "/membership/join-aaoe", "/membership/benefits/aaoe", "https://secure.aao.org/aao/aao-pay-dues#/", "/practice-management/about-aaoe", "/practice-management/about/board", "/practice-management/about/content-committee", "/practice-management/get-involved", "/clinical-teams", "/clinical-teams/aaop-membership/join-aaop", "/clinical-teams/education", "/clinical-teams/build-your-career", "/clinical-teams/annual-meeting", "/clinical-teams/about-aaop", "/eye-health", "/eye-health/a-z", "/eye-health/symptoms-list", "/eye-health/glasses-contacts-list", "/eye-health/tips-prevention-list", "/eye-health/news-list", "/eye-health/ask-ophthalmologist", "/eye-health/patient-stories", "/no-cost-eye-exams", "/eye-health/espanol", "/salud-ocular/a-z", "/salud-ocular/sintomas-lista", "/salud-ocular/anteojos-lentes-de-contacto-lista", "/salud-ocular/consejos-lista", "/salud-ocular/noticias-lista", "/salud-ocular/relatos-de-pacientes", "/salud-ocular/ex-menes-de-la-vista-sin-costo", "/salud-ocular/english", "/annual-meeting", "/annual-meeting/meeting-information", "/annual-meeting/past-and-future-meetings", "/annual-meeting/mobile-meeting-guide", "/annual-meeting/contact", "/annual-meeting/news", "/annual-meeting/health-safety", "/annual-meeting/policies-and-disclaimers", "/program", "/annual-meeting/highlights", "/annual-meeting/subspecialty-day", "/annual-meeting/virtual-meeting", "/annual-meeting/program-committees", "/annual-meeting/cme", "/annual-meeting/meeting-archives", "/annual-meeting/exhibition", "/annual-meeting/registration", "/annual-meeting/hotel-reservation", "/annual-meeting/hotel-reservation", "/annual-meeting/san-francisco", "/annual-meeting/international-attendees", "/annual-meeting/hotel-meeting-space", "/annual-meeting/presenter", "/annual-meeting/presenter/overview", "/annual-meeting/presenter/abstract-selection-process", "/annual-meeting/presenter/submission-policies", "/annual-meeting/presenter/subject-classification-topics", "/annual-meeting/presenter/instruction-courses-and-skills-transfer-labs", "/annual-meeting/presenter/paper-posters", "/annual-meeting/presenter/videos", "/annual-meeting/presenter/grand-round", "/annual-meeting/presenter/guidelines", "/annual-meeting/presenter/faculty-development", "/annual-meeting/exhibitor", "/annual-meeting/exhibitor/general-information", "/annual-meeting/exhibitor/portal", "/annual-meeting/exhibitor/new-exhibiting-companies", "/annual-meeting/exhibitor/resources", "/annual-meeting/exhibitor/international-exhibitors", "/annual-meeting/exhibitor/promotional-opportunities", "/annual-meeting/exhibitor/hotel", "/about/who-we-are/overview", "/about/who-we-are/overview", "/about/what-we-do", "/eye-health/tips-prevention/what-is-ophthalmologist", "/about/eye-care-team", "/about/ethics", "/about/history", "/museum-of-vision", "/about/who-we-are/values", "/about/governance/overview", "/about/governance/council", "https://secure.aao.org/aao/Rosters/Board-Of-Trustees", "/about/governance/committees", "/about/governance/past-presidents", "https://secure.aao.org/aao/Rosters/Committee-of-secretaries", "/about/governance/elections", "/about/governance/academy-blog", "/governance/staff-leadership", "/about/leadership-development/overview", "/about/awards/program", "/about/awards/laureate", "/about/awards/advocate", "/about/awards/humanitarian", "/about/awards/blindness-prevention", "/about/awards/distinguished-service", "/about/awards/guests-of-honor", "/about/awards/secretariat", "/about/awards/straatsma", "/about/awards/achievement", "/about/awards/artemis", "/about/awards/energEYES", "/about/awards/international-education", "/about/awards/international-scholar", "/about/awards/commitment-to-advocacy", "/about/awards/visionary-society-award", "/about/financial-relationships", "/about/policies", "/about/related-organizations/overview", "https://secure.aao.org/aao/Rosters/Subspecialty-and-Special-Interest-Societies", "https://secure.aao.org/aao/Rosters/State-societies", "/about/related-organizations/overview", "/about/related-organizations/state-society-meetings", "/about/related-organizations/society-resources", "/about/year-in-review", "/about/2022-year-in-review", "/foundation", "/foundation/about", "/foundation/2022-annual-report", "/foundation/annual-report", "/foundation/news-from-the-chair", "/foundation/staff", "/foundation/our-impact", "/foundation/partners-for-sight", "/foundation/donor", "/foundation/global-ophthalmic-community", "/foundation/corporate-support/sponsorships", "/foundation/patients-and-the-public", "/foundation/giving-options", "/foundation/our-supporters", "https://aao.planmylegacy.org/", "/foundation/ophthalmic-business-council", "/foundation/parke-center-campaign", "/foundation/parke-center-campaign", "/foundation/museum-campaign", "/foundation/gala-overview", "/foundation/orbital-why-attend", "/foundation/gala-support-opportunities", "/foundation/orbital-gala-sponsors", "https://secure.aao.org/aao/faao", "/foundation/museum-campaign", "/foundation/museum-donor-honor-roll", "/museum-of-the-eye", "/visit-museum", "/museum-galleries", "/special-exhibitions", "/museum-events", "/museum/previous-events", "/museum-research-resources", "/museum-search", "/previous-exhibits", "/oral-histories", "/museum-biographies", "/museum-volunteer", "/museum-mailing", "/museum/donate", "/about-the-museum", "/museum-blog", "/young-ophthalmologists", "/young-ophthalmologists/yo-info", "/young-ophthalmologists/learn-to-code", "/young-ophthalmologists/grow-in-leadership", "/young-ophthalmologists/practice-management-yos", "https://ophthjobs.aao.org/", "/senior-ophthalmologists", "/senior-ophthalmologists/scope", "/senior-ophthalmologists/practice-transitions", "/international", "/international/programs", "/international/awards", "/international/outreach", "/residents", "/medical-students", "https://store.aao.org", "/", "/about/who-we-are/overview", "/academy-forum", "/advocacy-overview", "/annual-meeting", "/clinical-education", "/eyecare-america", "/eyenet", "/eye-health", "/salud-ocular", "/foundation", "/membership", "/museum-of-the-eye", "/practice-management", "/senior-ophthalmologists", "/young-ophthalmologists", "/international", "/iris-registry", "/test-page", "/clinical-team", "https://secure.aao.org/aao/Login?returnUrl=https%3a%2f%2fwww.aao.org%2fsalud-ocular%2fconsejos%2fmedicamentos-para-el-ojo-seco-mejorados-para-2022-", "https://secure.aao.org/aao/CreateAccount?TabId=191?ReturnUrl=%2fsalud-ocular%2fconsejos%2fmedicamentos-para-el-ojo-seco-mejorados-para-2022-", "https://secure.aao.org/aao/find-ophthalmologist", "javascript:void(0);", "/ophthalmologists", "/practice-management", "/clinical-teams", "/public-patients", "/about", "/foundation", "/museum-of-the-eye", "/salud-ocular/a-z", "/salud-ocular/sintomas-lista", "/salud-ocular/anteojos-lentes-de-contacto-lista", "/salud-ocular/consejos-lista", "/salud-ocular/noticias-lista", "/salud-ocular/relatos-de-pacientes", "/salud-ocular/ex-menes-de-la-vista-sin-costo", "/salud-ocular/english", "/salud-ocular-nav", "/salud-ocular/consejos-lista", "javascript:void(0)", null, "/eye-health/tips-prevention/new-dry-eye-treatments-ocular-surface-disease", "https://www.linkedin.com/in/reena-mukamal-2736a05/", "/biography/74606de6-3622-47fc-81e1-ad29f657e630", "/salud-ocular/enfermedades/ojo-seco", "/salud-ocular/consejos/como-puedo-saber-la-causa-de-mi-ojo-seco", "/salud-ocular/tratamientos/tapones-lagrimales", "/salud-ocular/consejos/12-tratamientos-para-el-ojo-seco-lo-que-los-pacien", "https://www.tyrvaya.com/", "/salud-ocular/anatomia/pelicula-lagrimal", "https://www.restasis.com/", "https://www.restasis.com/", "https://www.xiidra.com/", "https://www.eysuvis.com/", "https://www.mc2therapeutics.com/pipeline-products/", "https://www.novaliq.com/products/cyclasol/", "/salud-ocular/anatomia/glandulas-de-meibomio", "/salud-ocular/anatomia/parpado", "https://www.ophthalmologytimes.com/view/bausch-lomb-announces-topline-results-for-phase-iii-trial-of-nov03-to-treat-ded-associated-with-mgd", "https://www.businesswire.com/news/home/20210303005272/en/Azura-Ophthalmics-Announces-Positive-Topline-Results-From-Phase-2-Program-of-the-Company%E2%80%99s-Investigational-Treatment-for-Meibomian-Gland-Dysfunction", "/salud-ocular/enfermedades/que-es-la-blefaritis", "https://www.nature.com/articles/d43747-021-00059-1", "/salud-ocular/enfermedades/alergias", "https://www.healio.com/news/ophthalmology/20210427/reproxalap-meets-endpoints-in-phase-3-allergic-conjunctivitis-trial", "http://iactapharma.com/products/ic-265/", "/salud-ocular/enfermedades/que-es-la-uveitis", "https://oculis.com/ocs-02-uveitis/", "https://www.aao.org/salud-ocular/consejos-lista", "/salud-ocular/consejos/agudeza-visual", "/salud-ocular/consejos/agudeza-visual", "/biography/bcd5e286-e146-4106-97dd-dff47a008c47", "/salud-ocular/consejos/informaci%c3%b3n-sobre-salud-ocular-para-adultos-mayore", "/salud-ocular/consejos/informaci%c3%b3n-sobre-salud-ocular-para-adultos-mayore", "/biography/eac93724-3619-4834-8f38-50520c476300", "/salud-ocular/consejos/informaci%c3%b3n-para-la-salud-ocular-en-adultos-menore", "/salud-ocular/consejos/informaci%c3%b3n-para-la-salud-ocular-en-adultos-menore", "/biography/eac93724-3619-4834-8f38-50520c476300", "/salud-ocular/consejos/informaci%c3%b3n-de-salud-ocular-para-adultos-de-40-65-", "/salud-ocular/consejos/informaci%c3%b3n-de-salud-ocular-para-adultos-de-40-65-", "/biography/eac93724-3619-4834-8f38-50520c476300", "/salud-ocular/consejos/enfermedades-y-afecciones-oculares-de-la-ninez", "/salud-ocular/consejos/enfermedades-y-afecciones-oculares-de-la-ninez", "/biography/272fced2-36d7-470a-b14a-0dcb2cee253b", "https://secure.aao.org/aao/encontrar-oftalmologo", "/contact", "/about", "/jobs", "/about/financial-relationships", "/salud-ocular/terminos-de-servicio#med", "/salud-ocular/politica-de-privacidad", "/salud-ocular/terminos-de-servicio", "/statement-on-artificial-intelligence", "/help", "/advertising-policies", "/newsroom", "https://ophthjobs.aao.org/", "http://eyewiki.aao.org", "https://www.isrs.org", "http://www.facebook.com/American-Academy-of-Ophthalmology", "http://twitter.com/aao_ophth", "http://www.linkedin.com/company/american-academy-of-ophthalmology", "/youtube-pro", "https://www.facebook.com/AcademyEyeSmart/", "https://twitter.com/AcademyEyeSmart", "https://www.instagram.com/aaoeye/", "/youtube-public", "https://www.facebook.com/Truhlsen-Marmor-Museum-of-Eye-106294080874158/", "https://twitter.com/museumoftheeye", "https://www.instagram.com/museumoftheeye/", "https://www.tripadvisor.com/Attraction_Review-g60713-d9715178-Reviews-Truhlsen_Marmor_Museum_of_the_Eye-San_Francisco_California.html", "https://www.yelp.com/biz/museum-of-the-eye-san-francisco"]}